A Randomized Trial of Modifications to Radical Prostatectomy
Condition: Prostate Cancer
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT01407263
Sponsor: Memorial Sloan Kettering Cancer Center
Phase: Phase 3
Eligibility:
- Age: minimum 21 Years maximum N/A
- Gender: Male
Inclusion Criteria:
- Patients do not have to be eligible for both modifications to be included in the study. Lymphadenectomy vs no lymphadenectomy:
- Patients 21 years or older scheduled for radical prostatectomy for treatment of prostate cancer with one of the consenting surgeons at MSKCC
Exclusion Criteria:
- Lymphadenectomy vs no lymphadenectomy
- Presence of positive/suspicious pelvic nodes on MRI, CT or PSMA scan (positive/suspicious defined as a pelvic node >15mm in short axis or a node with abnormal morphology such as roundness or irregularity or loss of fatty hilum
- Any prior pelvic radiation therapy used to treat prostate cancer
View trial on ClinicalTrials.gov